Literature DB >> 16981685

The extended family of neutral sphingomyelinases.

Christopher J Clarke1, Christopher F Snook, Motohiro Tani, Nabil Matmati, Norma Marchesini, Yusuf A Hannun.   

Abstract

The neutral sphingomyelinases (N-SMases) are considered major candidates for mediating the stress-induced production of ceramide, and N-SMase activity has been identified, characterized, and cloned from bacteria, yeast, and mammalian cells. Although the level of identity between these enzymes is low, a number of key residues thought to be involved in metal binding and catalysis are conserved. This has led to the suggestion of a common catalytic mechanism, and thus, these enzymes are considered to form an extended family of N-SMases. Despite considerable research into N-SMase activity in cell culture and various tissues, the lack, until recently, of molecular identification of specific N-SMase enzymes had precluded specific insights into the regulation, physiological, and pathological roles of these proteins. In this review, we summarize, for the first time, current knowledge of the N-SMase family, focusing on cloned members from bacteria, yeast, and mammalian cells. We also briefly consider the major future directions for N-SMase research which promises highly significant and specific insight into sphingolipid-mediated functions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16981685     DOI: 10.1021/bi061307z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  78 in total

1.  Neutral sphingomyelinase 2 activity and protein stability are modulated by phosphorylation of five conserved serines.

Authors:  Simone Filosto; Majid Ashfaq; Samuel Chung; William Fry; Tzipora Goldkorn
Journal:  J Biol Chem       Date:  2011-11-10       Impact factor: 5.157

2.  Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-α.

Authors:  Brian M Barth; Sally J Gustafson; Thomas B Kuhn
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

3.  Role of ceramides in nonalcoholic fatty liver disease.

Authors:  Mangesh Pagadala; Takhar Kasumov; Arthur J McCullough; Nizar N Zein; John P Kirwan
Journal:  Trends Endocrinol Metab       Date:  2012-05-17       Impact factor: 12.015

4.  A toxin-based probe reveals cytoplasmic exposure of Golgi sphingomyelin.

Authors:  Biserka Bakrac; Ales Kladnik; Peter Macek; Gavin McHaffie; Andreas Werner; Jeremy H Lakey; Gregor Anderluh
Journal:  J Biol Chem       Date:  2010-05-12       Impact factor: 5.157

5.  Proteomic Profiling of Detergent Resistant Membranes (Lipid Rafts) of Prostasomes.

Authors:  Louise Dubois; Karl K Göran Ronquist; Bo Ek; Gunnar Ronquist; Anders Larsson
Journal:  Mol Cell Proteomics       Date:  2015-08-13       Impact factor: 5.911

Review 6.  The neutral sphingomyelinase family: identifying biochemical connections.

Authors:  Christopher J Clarke; Bill X Wu; Yusuf A Hannun
Journal:  Adv Enzyme Regul       Date:  2010-10-28

Review 7.  Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.

Authors:  Catherine Pavoine; Françoise Pecker
Journal:  Cardiovasc Res       Date:  2009-01-28       Impact factor: 10.787

8.  Confluence induced threonine41/serine45 phospho-beta-catenin dephosphorylation via ceramide-mediated activation of PP1cgamma.

Authors:  Norma Marchesini; Jeffrey A Jones; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2007-11-08

Review 9.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

10.  The Polycomb group protein EED couples TNF receptor 1 to neutral sphingomyelinase.

Authors:  Stephan Philipp; Malte Puchert; Sabine Adam-Klages; Vladimir Tchikov; Supandi Winoto-Morbach; Sabine Mathieu; Andrea Deerberg; Ljudmila Kolker; Norma Marchesini; Dieter Kabelitz; Yusuf A Hannun; Stefan Schütze; Dieter Adam
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.